Nitric oxide in tumour biology and cancer therapy. Part 2: Therapeutic implications

Clinical Oncology

Volumn 9, Issue 6, 1997, Pages 357-364

  Tozer, G M ^a   Everett, S A ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOETHYLAMINO) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 5 (1 AZIRIDINYL) 3 HYDROXYMETHYL 2 (3 HYDROXY 1 PROPENYL) 1 METHYL 4,7 INDOLEDIONE; ARGININE DERIVATIVE; GROWTH PROMOTOR; IMIDAZOLE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PRODRUG; TIRAPAZAMINE; UNINDEXED DRUG; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER;

CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER THERAPY; CELL PROTECTION; CYTOSTASIS; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; HUMAN; HYPOTENSION; HYPOXIC CELL; MACROPHAGE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; REVIEW; TUMOR BLOOD FLOW; TUMOR GROWTH; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; BLOOD FLOW VELOCITY; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL NEOPLASM; METABOLISM; MICROCIRCULATION; NEOPLASM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; BLOOD FLOW VELOCITY; CELL DIVISION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; MICROCIRCULATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; TREATMENT OUTCOME;

EID: 0031307208     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80128-8     Document Type: Review

References (91)

1. Tozer GM Everett SA Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects Clin Oncol 7 1997 282 293
2. Hibbs JB Taintor RR Vavrin Z Nitric oxide: a cytotoxic activated macrophage effector molecule Biochem Biophys Res Commun 157 1988 87 94
3. Stuehr DJ Nathan CF Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells J Exp Med 169 1989 1543 1555
4. Farias-Eisner R Sherman MP Aeberhard E Nitric oxide is an important mediator for tumoricidal activity in vivo Proc Natl Acad Sci USA 91 1994 9407 9411
5. Li L Kilbourn RG Adams J Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells Cancer Res 51 1991 2531 2535
6. Xie K Huang S Dong Z Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene J Natl Cancer Inst 89 1997 421 427
7. Sarih M Souvannavong V Adam A Nitric oxide synthase induces macrophage death by apoptosis Biochem Biophys Res Commun 191 1993 503 508
8. Meßmer UK Ankarcrona M Nicotera P p53 expression in nitric oxide-induced apoptosis FEBS Lett 355 1994 23 26
9. Meßmer UK Lapetina EG Brune B Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds Mol Pharmacol 47 1995 757 765
10. Shimaoka M Iida T Ohara A NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages Biochem Biophys Res Commun 209 1995 519 526
11. Meßmer UK Reimer DM Reed JC Nitric oxide induced poly(SADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by bcl -2 FEBS Lett 384 1996 162 166
12. Cui S Reichner JS Mateo RB Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms Cancer Res 54 1994 2462 2467
13. Maragos CM Wang JM Hrabie JA Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release Cancer Res 53 1993 564 568
14. Tamir S Burney S Tannenbaum S DNA damage by nitric oxide Chem Res Toxicol 9 1996 821 827
15. Burney S Tamir S Gal A A mechanistic analysis of nitric oxide-induced cellular toxicity Nitric Oxide 1 1997 130 144
16. Lepoivre M Fieschi F Coves J Inactivation by ribonculeotide reductase by nitric oxide Biochem Biophys Res Commun 179 1991 442 448
17. Lepoivre M Flaman J-M Henry Y Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide J Biol Chem 267 1992 22994 23000
18. Lepoivre M Flaman JM Bobe P Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide J Biol Chem 269 1994 21891 21897
19. Okamoto K Toyokuni S Uchida K Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carconoma Int J Cancer 58 1994 825 829
20. Buttke TM Sandstrom PA Oxidative stress as a mediator of apoptosis Immunol Today 15 1994 7 10
21. Lin KT Xue JY Nomen M Peroxynitrite-induced apoptosis in HL-60 cells J Biol Chem 270 1995 16487 16490
22. Kuo ML Chau YP Wang JH Inhibitors of poly(ADP)-ribose polymerase block nitric oxide-induced apoptosis but not differentiation in human leukaemia HL-60 cells Biochem Biophys Res Commun 219 1996 502 508
23. Hockenbery DM Oltvai ZN Yin XM bcl -2 functions in an antioxidant pathway to prevent apoptosis Cell 75 1993 241 251
24. Sandstrom PA Pardi D Tebbey PW Lipid hydroperoxide-induced apoptosis: lack of inhibition by bcl -2 over-expression FEBS Lett 365 1995 66 70
25. Brown GC Reversible binding and inhibition of catalase by nitric oxide Eur J Biochem 232 1995 188 191
26. Asahi M Fujii J Suzuki K Inactivation of glutathione peroxidase by nitric oxide J Biol Chem 270 1996 21035 21039
27. Kröncke K-D Fehsel K Kolb-Bachofen V Nitric oxide: cytotoxicity versus cytoprotection — how, why, when, and where Nitric Oxide 1 1997 107 120
28. Rubbo H Darley-Usmar V Freeman B Nitric oxide regulation of tissue free radical injury Chem Res Toxicol 9 1996 809 820
29. Wink DA Hanbauer I Krishna MC Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species Proc Natl Acad Sci USA 90 1993 9813 9817
30. Parks DA Granger N Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals Am J Physiol 245 1983 G285 G289
31. Chaplin DJ Olive PL Durand RE Intermittent blood flow in a murine tumor: radiobiological effects Cancer Res 47 1987 597 601
32. Chaplin DJ Hill SA Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours Br J Cancer 71 1995 1210 1213
33. Parkins CS Dennis MF Stratford MRL Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide Cancer Res 55 1995 6026 6029
34. Parkins CS Hill SA Stratford MRL Metabolic and clonogenic consequences of ischaemia-reperfusion insult in solid tumorus Exp Physiol 82 1997 361 368
35. Thomsen LL Lawton FG Knowles RG Nitric oxide synthase activity in human gynecological cancer Cancer Res 54 1994 1352 1354
36. Cobbs CS Brenman JE Aldape KD Expression of nitric oxide synthase in human central nervous system tumors Cancer Res 55 1995 727 730
37. Thomsen LL Miles DW Happerfield L Nitric oxide synthase activity in human breast cancer Br J Cancer 72 1995 41 44
38. Kennovin GD Hirst DG Stratford MRL Inducible nitric oxide synthase is expressed in tumour-associated vasculature: inhibition retards tumour growth in vivo Moncada S Feelisch M Busse R The biology of nitric oxide 4: Enzymology, biochemistry and immunology 1994 Portland Press London 473 479
39. G-nitro- l -arginine methyl ester, an inhibitor of nitric oxide synthesis ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice Br J Cancer 73 1996 189 196
40. Jenkins DC Charles IG Thomsen LL Roles of nitric oxide in tumor growth Proc Natl Acad Sci USA 92 1995 4392 4396
41. Pipili-Synetos E Papageorgiou A Sakkoula E Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate Br J Pharmacol 116 1995 1829 1834
42. DiNapoli MR Calderon CL Lopez DM The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene J Exp Med 183 1996 1323 1329
43. Ambs S Merriam WG Bennet WP Interaction of nitric oxide and p53 in tumor growth: a putative mode for clonal selection of mutant p53 cells 88th Annual Meeting of American Association for Cancer Research San Diego 1997 273
44. WAFI controls differentiation of PC12 cells 88th Annual Meeting of American Association for Cancer Research San Diego 1997 498
45. Dong Z Staroselsky AH Qi X Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells Cancer Res 54 1994 789 793
46. Xie K Huang S Dong Z Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells J Exp Med 181 1995 1333 1343
47. Thomsen LL Miles DW Happerfield L Nitric oxide synthase in human breast cancer tissue is localized within macrophages Moncada S Feelisch M Busse R The biology of nitric oxide 4: Enzymology, biochemistry and immunology 1994 Portland Press London 463 466
48. Rocha M Krüger A Van Rooijen N Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo Int J Cancer 63 1995 405 411
49. G-nitro- l -arginine and/or l -arginine on experimental pulmonary metastasis in mice Cancer Lett 87 1994 115 120
50. Rees DD Palmer RMJ Schulz R Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo Br J Pharmacol 101 1990 746 752
51. Gardiner SM Kemp PA March JE Cardiac and regional haemodynamics: inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats Br J Pharmacol 116 1995 2005 2016
52. Tozer GM Prise VE Chaplin DJ Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with l -aginine Cancer Res 57 1997 948 955
53. Marietta MA Approaches toward selective inhibition of nitric oxide synthase J Med Chem 37 1994 1899 1907
54. (Suppl) Stratford IJ Bioreductive drugs in cancer therapy Br J Radiol 24 1992 128 136
55. Horsman MR Christensen KL Overgaard J Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo Int J Hyperthermia 5 1989 123 136
56. Teicher BA Lazo JS Sartorelli AC Classification of antineoplastic agents by their selective toxicities oxygenated and hypoxic tumour cells Cancer Res 41 1981 73 81
57. Wood P Stratford IJ Adams GE Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability Biochem Biophys Res Commun 192 1993 505 510
58. Wood PJ Sansom JM Stratford IJ Modification of metabolism of transplantable and spontaneous murine tumors by the nitric oxide synthase inhibitor, nitro- l -arginine Int J Radiat Oncol Biol Phys 29 1994 443 447
59. G-nitro- l -arginine Cancer Res 54 1994 6458 6463
60. Horsman MR Chaplin DJ Hill SA Effect of nitro- l -arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours Br J Cancer 74 Suppl XXVII 1996 S168 S171
61. Butler Enhancement of the bioreductive drug toxicity in murine tumours by inhibition of nitric oxide synthase Br J Cancer 76 1997 438 444
62. Tozer GM Prise VE Bell KM Reduced capacity of tumour blood vessels to produce EDRF: significance of tumour blood flow modification Br J Cancer 74 1996 1955 1960
63. Wood PJ Sansom JM Stratford IJ Changes in energy metabolism and X-ray sensitivity in murine tumours by the nitric oxide donor SIN-1 Br J Cancer 74 Suppl XXVII 1996 S177 S180
64. Howard-Flanders P Effect of nitric oxide on the radiosensitivity of bacteria Nature 30 1957 l191 l192
65. Gray LH Green FO Hawes CA Effect of nitric oxide on the radiosensitivity of tumour cells Nature 182 1958 952 953
66. Mitchell JB Wink DA DeGraff W Hypoxic mammalian cell radiosensitization by nitric oxide Cancer Res 53 1993 5845 5848
67. Sagar S Singh G Hodson DI Nitric oxide and anticancer therapy Cancer Treat Rev 21 1995 159 181
68. Howes AE Page A Fowler JF The effect of single and fractionated doses of X-rays on the effective proportion of hypoxic cells in C3H mouse mammary tumours Br J Radiol 45 1972 250 256
69. Kilbourn RG Belloni P Endothelial cell production of nitrogen oxides in response to interferon-gamma in combination with tumour necrosis factor, interleukin-1 or endotoxin J Natl Cancer Inst 82 1990 772 775
70. Citterio G Pellegatta F Lucca GD Plasma nitrate plus nitrite changes during continuous intravenous infusion of interleukin 2 Br J Cancer 74 1996 1297 1301
71. Gárban HJ Bonavida B Nitric oxide up-regulates fas receptor expression and sensitizes the AD10 ovarian carcinoma cell line to fas -mediated apoptosis 88th Annual Meeting of American Association for Cancer Research San Diego, CA 1997 626
72. Kwak J-Y Samlowski WE Sohn M-H Induction of nitric oxide (NO) synthesis in DLD-1 human colon cancer cells via cytokines secreted by IL-2-activated peripheral blood lymphocytes (PBL) 88th Annual Meeting American Assocation for Cancer Research San Diego, CA 1997 302
73. Orucevic A Hern S Lala PK The role of active inducible nitric oxide synthase expression in the pafhogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice Lab Invest 76 1997 53 65
74. Baguley BC Holdaway KM Thomsen LL Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism Eur J Cancer 27 1991 482 487
75. Chaplin DJ Pettit GR Parkins CS Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents Br J Cancer 74 Suppl XXVII 1996 S86 S88
76. Hill SA Lonargan SJ Denekamp J Vinca alkaloids: anti-vascular effects in a murine tumour Eur J Cancer 29A 1993 1320 1324
77. Hill SA Sampson LE Chaplin DJ Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid Int J Cancer 63 1995 119 123
78. Thomsen LI Ching L-M Zhuang L Tumor-dependent increased plasma nitrate concentrations as an indication of the anti-tumor effect of flavone-8-acetic acid and analogues in mice Cancer Res 51 1991 77 81
79. Mahadevan V Malik STA Meager A Role of tumour necrosis factor in flavone acetic acid induced vascular shutdown Cancer Res 50 1990 5537 5542
80. de Wilt JHW Manusama ER van Tiel ST Nitric oxide (NO) inhibition enhances tumour necrosis factor α and melphalan antitumor activity in rats 88th Annual Meeting American Association for Cancer Research San Diego, CA 1997 321
81. Adams GE Stratford IJ Bioreductive drugs for cancer therapy: the search for tumor specificity Int J Radiat Oncol Biol Phys 29 1994 231 238
82. Denny WA Wilson WR Hay MP Recent developments in the design of bioreductive drugs Br J Cancer 74 Suppl XXVII 1996 S32 S38
83. Ulhaq S Naylor MA Chinje EC S -2-amino-5-(2-nitroimidazol-1-yl)-pentanoic acid: a model for potential bioreductively activated prodrugs for inhibitors of nitric oxide synthase (NOS) activity Anticancer Drug Design 12 1997 61 65
84. ω-hydroxyl- l -arginine by hemeproteins Biochem Biophys Res Commun 184 1992 1158 1164
85. Jousserandot A Boucher JL Desseaux C Formation of nitrogen oxides including NO from oxidative cleavage of C=N(OH) bonds: a general cytochrome P450-dependent reaction Bioorg Med Chem Lett 5 1995 423 426
86. ω-hydroxy- l -arginine by the superoxide anion-radical Biochem J 317 1996 17 21
87. Everett SA Smith KA Patel KB Nitric oxide involvement in the toxicity of hydroxyguanidine in leukaemia HL60 cells Br J Cancer 73 Suppl XXVII 1996 S172 S176
88. Pacelli R Taira J Cook J Hydroxyurea reacts with heme proteins to generate nitric oxide Lancet 347 1996 900
89. (in press) Dachs GU Dougherty GJ Stratford IJ Chaplin DJ Targeting gene therapy to cancer: A review Oncol Res 1997
90. Witteveen FB Giovanelli J Kaufman S Reduction of quinoid dihydrobiopterin to tetrahydrobiopterin by nitric oxide synthase J Biol Chem 271 1996 4143 4147
91. Abu-Soud HM Rousseau DL Stuehr DJ Nitric oxide binding to the heme of neuronal nitric oxide synthase links its activity to changes in oxygen tension J Biol Chem 271 1996 32515 32518